All In Biotech

Drug Trial Radar · NCT06843018

Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges

A Prospective, Open-label, Multicenter, Comparative, Randomised, Parallel-group Study to Evaluate the Efficacy and Safety of Different Doses of the Drug Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges

Last checked: Nov 20, 2026Latest source record: Jul 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Nov 14, 2024

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Valenta Pharm JSCIndustry
Sponsor type
Industry
First posted
Feb 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to evaluete of tthe efficacy and safety of using different doses of the drug Grammidin with anesthetic, a metered dose topical spray, in the treatment of acute infectious and inflammatory pharyngeal diseases.

Conditions

  • Pharyngitis Acute
  • Pharyngitis
  • Nasopharyngitis
  • Exacerbation of Chronic Pharyngitis

Interventions

  • Grammidin with anestheticDrug

    Grammidin with anesthetic, a metered dose topical spray

  • Septolete TotalDrug

    Septolete Total, lozenges 3 mg + 1 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Combined primary efficacy endpoint: VAS + TPATime frame: Day 1 (Visit 1) - Day 8 (Visit 3)

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • State autonomous health care institution "Engels City Clinical Hospital No. 1"

    Engel's, Russia · Recruiting

  • State Budgetary Healthcare Institution of the Kaliningrad Region "City Hospital No. 2."

    Kaliningrad, Russia · Recruiting

  • Unimed-C Jsc

    Moscow, Russia · Recruiting

  • Professors' Clinic LLC.

    Perm, Russia · Recruiting

  • Limited Liability Company "Medical Center Eco-Safety"

    Saint Petersburg, Russia · Recruiting

  • Aurora MedFort LLC

    Saint Petersburg, Russia · Recruiting

  • St. Petersburg State Budgetary Healthcare Institution "City Polyclinic No. 117"

    Saint Petersburg, Russia · Recruiting

  • Limited Liability Company "Clinic Zvezdnaya"

    Saint Petersburg, Russia · Recruiting

  • Limited Liability Company "Meili"

    Saint Petersburg, Russia · Recruiting

  • LLC "Mariel Clinic"

    Saint Petersburg, Russia · Recruiting

  • LLC "Center for DNA Research"

    Saratov, Russia · Recruiting

  • LLC "Polyclinic Polimedika Veliky Novgorod"

    Velikiy Novgorod, Russia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.